Omega Healthcare Net Worth

Omega Healthcare Net Worth Breakdown

  OHI
The net worth of Omega Healthcare Investors is the difference between its total assets and liabilities. Omega Healthcare's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Omega Healthcare's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Omega Healthcare's net worth can be used as a measure of its financial health and stability which can help investors to decide if Omega Healthcare is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Omega Healthcare Investors stock.

Omega Healthcare Net Worth Analysis

Omega Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Omega Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Omega Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Omega Healthcare's net worth analysis. One common approach is to calculate Omega Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Omega Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Omega Healthcare's net worth. This approach calculates the present value of Omega Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Omega Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Omega Healthcare's net worth. This involves comparing Omega Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Omega Healthcare's net worth relative to its peers.

Enterprise Value

472.57 Million

To determine if Omega Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Omega Healthcare's net worth research are outlined below:
Over 77.0% of the company shares are owned by institutional investors
On 18th of February 2025 Omega Healthcare paid $ 0.67 per share dividend to its current shareholders
Latest headline from globenewswire.com: Global Fish Oil Market to Reach USD 24,624.1 Million by 2035, Driven by Rising Demand for Omega-3 Supplements Future Market Insights, Inc.
Omega Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Omega Healthcare Investors. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Omega Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Omega Healthcare Target Price Consensus

Omega target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Omega Healthcare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   17  Buy
Most Omega analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Omega stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Omega Healthcare Inv, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Omega Healthcare Target Price Projection

Omega Healthcare's current and average target prices are 38.00 and 42.40, respectively. The current price of Omega Healthcare is the price at which Omega Healthcare Investors is currently trading. On the other hand, Omega Healthcare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Omega Healthcare Market Quote on 24th of March 2025

Low Price37.2Odds
High Price38.08Odds

38.0

Target Price

Analyst Consensus On Omega Healthcare Target Price

Low Estimate38.58Odds
High Estimate47.06Odds

42.4

Historical Lowest Forecast  38.58 Target Price  42.4 Highest Forecast  47.06
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Omega Healthcare Investors and the information provided on this page.

Know Omega Healthcare's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Omega Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Omega Healthcare Investors backward and forwards among themselves. Omega Healthcare's institutional investor refers to the entity that pools money to purchase Omega Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Norges Bank2024-12-31
2.9 M
Centersquare Investment Management Llc2024-12-31
2.7 M
Bank Of America Corp2024-12-31
2.4 M
Morgan Stanley - Brokerage Accounts2024-12-31
2.2 M
Amundi2024-12-31
M
Ubs Asset Mgmt Americas Inc2024-12-31
1.8 M
Jpmorgan Chase & Co2024-12-31
1.7 M
Legal & General Group Plc2024-12-31
1.6 M
Ubs Group Ag2024-12-31
1.6 M
Vanguard Group Inc2024-12-31
38.1 M
Blackrock Inc2024-12-31
34.5 M
Note, although Omega Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Omega Healthcare's market capitalization trends

The company currently falls under 'Large-Cap' category with a total capitalization of 10.81 B.

Market Cap

5.69 Billion

Project Omega Healthcare's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.04  0.03 
Return On Capital Employed 0.10  0.08 
Return On Assets 0.04  0.03 
Return On Equity 0.09  0.06 
The company has Net Profit Margin of 0.39 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.63 %, which entails that for every 100 dollars of revenue, it generated $0.63 of operating income.
When accessing Omega Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Omega Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Omega Healthcare's profitability and make more informed investment decisions.

Evaluate Omega Healthcare's management efficiency

Omega Healthcare Inv has Return on Asset of 0.0434 % which means that on every $100 spent on assets, it made $0.0434 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0984 %, implying that it generated $0.0984 on every 100 dollars invested. Omega Healthcare's management efficiency ratios could be used to measure how well Omega Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.03. The current Return On Capital Employed is estimated to decrease to 0.08. As of now, Omega Healthcare's Other Current Assets are decreasing as compared to previous years. The Omega Healthcare's current Fixed Asset Turnover is estimated to increase to 38.00, while Non Current Assets Total are projected to decrease to under 611.5 M.
Last ReportedProjected for Next Year
Book Value Per Share 18.33  18.58 
Tangible Book Value Per Share 15.83  17.47 
Enterprise Value Over EBITDA 14.88  8.86 
Price Book Value Ratio 2.15  1.27 
Enterprise Value Multiple 14.88  8.86 
Price Fair Value 2.15  1.27 
Enterprise Value737.2 M472.6 M
Examining the leadership quality of Omega Healthcare Investors offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue
14.1268
Revenue
1.1 B
Quarterly Revenue Growth
0.167
Revenue Per Share
4.073
Return On Equity
0.0984
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omega Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omega Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omega Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Omega Healthcare Corporate Filings

10K
13th of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
6th of February 2025
Other Reports
ViewVerify
F4
21st of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
10th of January 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
Omega Healthcare time-series forecasting models is one of many Omega Healthcare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Omega Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Omega Healthcare Earnings Estimation Breakdown

The calculation of Omega Healthcare's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Omega Healthcare is estimated to be 0.32 with the future projection ranging from a low of 0.43 to a high of 0.4562. Please be aware that this consensus of annual earnings estimates for Omega Healthcare Investors is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.4
0.43
Lowest
Expected EPS
0.32
0.46
Highest

Omega Healthcare Earnings Projection Consensus

Suppose the current estimates of Omega Healthcare's value are higher than the current market price of the Omega Healthcare stock. In this case, investors may conclude that Omega Healthcare is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Omega Healthcare's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
1759.88%
0.3969
0.32
1.55

Omega Healthcare Earnings per Share Projection vs Actual

Actual Earning per Share of Omega Healthcare refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Omega Healthcare Investors predict the company's earnings will be in the future. The higher the earnings per share of Omega Healthcare, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Omega Healthcare Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Omega Healthcare, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Omega Healthcare should always be considered in relation to other companies to make a more educated investment decision.

Omega Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Omega Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-05
2024-12-310.41430.3969-0.0174
2024-10-30
2024-09-300.380.420.0410 
2024-08-01
2024-06-300.350.450.128 
2024-05-02
2024-03-310.320.27-0.0515 
2024-02-07
2023-12-310.350.22-0.1337 
2023-11-02
2023-09-300.330.370.0412 
2023-08-02
2023-06-300.310.25-0.0619 
2023-05-02
2023-03-310.280.15-0.1346 
2023-02-02
2022-12-310.550.19-0.3665 
2022-11-02
2022-09-300.370.430.0616 
2022-08-01
2022-06-300.370.380.01
2022-05-02
2022-03-310.320.790.47146 
2022-02-02
2021-12-310.470.14-0.3370 
2021-11-04
2021-09-300.430.580.1534 
2021-08-02
2021-06-300.410.36-0.0512 
2021-05-03
2021-03-310.450.690.2453 
2021-02-04
2020-12-310.410.27-0.1434 
2020-10-29
2020-09-300.38-0.4-0.78205 
2020-08-05
2020-06-300.390.430.0410 
2020-05-04
2020-03-310.420.39-0.03
2020-02-05
2019-12-310.370.27-0.127 
2019-11-05
2019-09-300.40.630.2357 
2019-08-06
2019-06-300.370.34-0.03
2019-05-07
2019-03-310.370.34-0.03
2019-02-11
2018-12-310.440.31-0.1329 
2018-11-05
2018-09-300.390.28-0.1128 
2018-08-03
2018-06-300.380.390.01
2018-05-07
2018-03-310.370.420.0513 
2018-02-13
2017-12-310.420.31-0.1126 
2017-10-30
2017-09-300.460.3-0.1634 
2017-07-26
2017-06-300.490.33-0.1632 
2017-05-03
2017-03-310.510.530.02
2017-02-08
2016-12-310.480.630.1531 
2016-10-31
2016-09-300.50.4-0.120 
2016-08-02
2016-06-300.50.570.0714 
2016-05-04
2016-03-310.480.29-0.1939 
2016-02-10
2015-12-310.380.32-0.0615 
2015-11-02
2015-09-300.410.430.02
2015-08-03
2015-06-300.40.22-0.1845 
2015-04-28
2015-03-310.480.32-0.1633 
2015-02-23
2014-12-310.460.44-0.02
2014-10-27
2014-09-300.450.50.0511 
2014-07-23
2014-06-300.410.38-0.03
2014-04-29
2014-03-310.410.450.04
2014-02-03
2013-12-310.340.32-0.02
2013-10-31
2013-09-300.330.340.01
2013-07-31
2013-06-300.340.420.0823 
2013-05-07
2013-03-310.320.340.02
2013-02-11
2012-12-310.280.30.02
2012-10-26
2012-09-300.270.270.0
2012-07-27
2012-06-300.250.290.0416 
2012-05-08
2012-03-310.250.250.0
2012-02-07
2011-12-310.210.19-0.02
2011-11-01
2011-09-300.210.210.0
2011-08-04
2011-06-300.20.17-0.0315 
2011-05-04
2011-03-310.17-0.11-0.28164 
2011-02-17
2010-12-310.180.03-0.1583 
2010-11-04
2010-09-300.260.15-0.1142 
2010-08-05
2010-06-300.140.140.0
2010-05-06
2010-03-310.210.210.0
2010-02-23
2009-12-310.220.18-0.0418 
2009-10-29
2009-09-300.20.220.0210 
2009-07-30
2009-06-300.230.21-0.02
2009-05-07
2009-03-310.250.270.02
2009-02-06
2008-12-310.250.19-0.0624 
2008-11-05
2008-09-300.20.330.1365 
2008-08-07
2008-06-300.240.260.02
2008-04-23
2008-03-310.290.23-0.0620 
2008-01-31
2007-12-310.210.220.01
2007-11-01
2007-09-300.210.19-0.02
2007-07-25
2007-06-300.270.2-0.0725 
2006-01-27
2005-12-310.140.11-0.0321 
2005-10-27
2005-09-300.150.03-0.1280 
2005-07-28
2005-06-300.09-0.05-0.14155 
2005-04-28
2005-03-310.150.11-0.0426 
2004-04-27
2004-03-310.2-1.29-1.49745 

Omega Healthcare Corporate Directors

Kapila AnandIndependent DirectorProfile
Burke WhitmanIndependent DirectorProfile
Edward LowenthalIndependent DirectorProfile
Kevin JacobsIndependent DirectorProfile
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.838
Dividend Share
2.68
Earnings Share
1.55
Revenue Per Share
4.073
Quarterly Revenue Growth
0.167
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.